Cingulate (CINGW) EPS (Basic) (2021 - 2026)
Cingulate's (CINGW) quarterly EPS (Basic) came in at -$0.45 in Q2 2026, up 60.79% on a YoY basis from -$0.28 in Q2 2025, and up 54.57% quarter-over-quarter from -$0.98 in Q4 2025.
Powered by 
Analysis
Cingulate (CINGW) EPS (Basic) (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported EPS (Basic) for 6 consecutive years, with -$0.45 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 60.79% year-over-year to -$0.45; the trailing twelve-month figure through Jun 2026 stood at -$1.64 (up 55.52% YoY), and the FY2025 full-year result was -$3.51, up 59.11% from the prior year.
- EPS (Basic) climbed to -$0.45 in Q2 2026 per CINGW's latest filing, from -$0.98 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.45 in Q2 2026 and bottomed at -$107.27 in Q2 2023.
- Historically, EPS (Basic) has averaged -$36.49 across 5 years, with a median of -$5.79 in 2024.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) slumped 58.36% in 2023, then jumped 96.78% in 2024.
- Over 5 years, EPS (Basic) stood at -$76.97 in 2022, then climbed by 5.54% to -$72.7 in 2023, then soared by 95.56% to -$3.23 in 2024, then surged by 69.64% to -$0.98 in 2025, then soared by 54.57% to -$0.45 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.45, -$0.98, and -$1.07 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.70 Bn | 623.94 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 441.16 Bn | 434.59 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.48 Bn | 258.79 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.53 Bn | 45.15 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.20 Bn | 44.20 Bn | - | -3.06 |
| 8 | Incyte | 25.27 Bn | 20.74 Bn | 1.57 Bn | 2.92 |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 7.82 |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | -0.45 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.45 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -1.07 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -3.23 |
| Sep 30, 2024 | -1.85 |
| Jun 30, 2024 | -4.26 |
| Mar 31, 2024 | -5.79 |
| Dec 31, 2023 | -72.70 |
| Sep 30, 2023 | -57.35 |
| Jun 30, 2023 | -107.27 |
| Mar 31, 2023 | -67.14 |
| Dec 31, 2022 | -76.97 |
| Sep 30, 2022 | -67.52 |
| Jun 30, 2022 | -67.74 |
| Mar 31, 2022 | -84.12 |
| Dec 31, 2021 | -85.91 |